Prosight Management, LP

CIK
1617201
City
DALLAS
State / Country
TX

Top Portfolio Positions

45 positions · $577,641,288 total · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio
NKTR
Nektar Therapeutics
Healthcare
735,000 $52,883,250 9.16%
BSX
Boston Scientific Corp
Healthcare
795,547 $49,920,574 8.64%
JANX
Janux Therapeutics, Inc.
Healthcare
3,550,000 $49,345,000 8.54%
PRCT
PROCEPT BioRobotics Corp
Healthcare
1,945,000 $48,644,450 8.42%
LKFT
Lakefront Biotherapeutics NV
Healthcare
1,550,000 $46,500,000 8.05%
WGS
GeneDx Holdings Corp.
Healthcare
523,463 $33,616,793 5.82%
ADCT
ADC Therapeutics SA
Healthcare
8,300,000 $31,125,000 5.39%
KURA
Kura Oncology, Inc.
Healthcare
3,356,700 $27,289,971 4.72%
ALNY
Alnylam Pharmaceuticals, Inc.
Healthcare
76,000 $25,146,120 4.35%
MGTX
MeiraGTx Holdings plc
Healthcare
2,629,971 $22,775,548 3.94%

Portfolio Trend

25 quarters · across all stocks

Holdings in ALKS

Export CSV

Shares Held

Position Value (USD)

9 of 9 shown
Report Date Value (USD) Shares
2026-03-31 $18,162,027 513,632
2024-06-30 $6,627,500 275,000
2024-03-31 $5,820,050 215,000
2023-12-31 $416,100 15,000
2023-09-30 $1,820,650 65,000
2023-06-30 $4,618,440 147,554
2023-03-31 $8,912,691 316,165
2022-12-31 $8,923,943 341,521
2022-09-30 $11,213,009 502,150